Yongan Meng
Overview
Explore the profile of Yongan Meng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu Y, Meng Y, Liang Y, Zhang Y, Chen B, Qiu J, et al.
Bioengineering (Basel)
. 2024 Sep;
11(9).
PMID: 39329691
Full-thickness macular hole (FTMH) leads to central vision loss. It is essential to identify patients with FTMH at high risk of postoperative failure accurately to achieve anatomical closure. This study...
2.
Meng Z, Chen Y, Li H, Zhang Y, Yao X, Meng Y, et al.
J Transl Med
. 2024 Apr;
22(1):358.
PMID: 38627718
Background: Diabetic macular edema (DME) is a leading cause of vision loss in patients with diabetes. This study aimed to develop and evaluate an OCT-omics prediction model for assessing anti-vascular...
3.
Chen Y, Jiang Y, Yao X, Li Y, Liu R, Lv W, et al.
BMC Public Health
. 2022 Oct;
22(1):1871.
PMID: 36207704
Aims: To investigate the proportion and risk factors of diabetic retinopathy (DR) by stages in less-developed rural areas in Hunan Province of China. Background: DR is common among people with...
4.
Meng Y, Long K, Chen J, Luo J
J Clin Med
. 2022 Jul;
11(13).
PMID: 35807191
This study compared the absorption of subretinal fluid (SRF) in patients with rhegmatogenous retinal detachment (RRD) with and without high myopia after scleral buckling (SB) and investigated the effect of...
5.
Meng Z, Chen Y, Wu W, Yan B, Meng Y, Liang Y, et al.
Front Endocrinol (Lausanne)
. 2022 Jun;
13:841813.
PMID: 35692390
Backgrounds: Diabetic retinopathy (DR), especially proliferative diabetic retinopathy (PDR), is the major cause of irreversible blindness in the working-age population. Increasing evidence indicates that immune cells and the inflammatory microenvironment...
6.
Meng Z, Chen Y, Wu W, Yan B, Zhang L, Chen H, et al.
Front Immunol
. 2022 Mar;
13:754645.
PMID: 35281030
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. UM develops and is sustained by inflammation and immunosuppression from the tumor microenvironment (TME). This study sought to...
7.
Meng Y, Lan H, Hu Y, Chen Z, Ouyang P, Luo J
J Diabetes Res
. 2022 Mar;
2022:4612554.
PMID: 35257013
Objectives: The foveal avascular zone (FAZ) is a biomarker for quantifying diabetic macular ischemia (DMI), to automate the identification and quantification of the FAZ in DMI, using an improved U-Net...
8.
Zhu Z, Meng Y, Kozak I, Xie M, Liang Y, Yan B, et al.
Front Med (Lausanne)
. 2021 Dec;
8:737537.
PMID: 34869430
To investigate the changes in the macular microvascular structure after anti-vascular endothelial growth factor (anti-VEGF) treatment in retinal vein occlusion (RVO) patients with and without macular ischemia. A total of...
9.
Liang Y, Yan B, Meng Z, Xie M, Liang Z, Zhu Z, et al.
Front Med (Lausanne)
. 2021 Sep;
8:699254.
PMID: 34568366
To compare the aqueous concentrations of inflammatory and angiogenetic factors in vitrectomized vs. non-vitrectomized eyes with diabetic macular edema (DME). Aqueous samples were obtained from 107 eyes with DME before...
10.
Long K, Meng Y, Chen J, Luo J
BMC Ophthalmol
. 2021 Feb;
21(1):86.
PMID: 33588767
Background: The purpose of this study is to assess the absorption of subretinal fluid (SRF) after scleral buckling (SB) surgery for the treatment of rhegmatogenous retinal detachment (RRD). We also...